Compound 1191
Identifiers
- Canonical SMILES:
Cc1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)c1
- IUPAC name:
3,5-dichloro-N-[(4-fluorophenyl)methyl]-2-hydroxy-N-[(3-methylphenyl)methyl]benzenesulfonamide
- InChi:
InChI=1S/C21H18Cl2FNO3S/c1-14-3-2-4-16(9-14)13-25(12-15-5-7-18(24)8-6-15)29(27,28)20-11-17(22)10-19(23)21(20)26/h2-11,26H,12-13H2,1H3
- InChiKey:
DYFGSTMZEIBNOO-UHFFFAOYSA-N
External links
![]() 58531610 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 266 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.14 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 453.04 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 6.04 | |||
TPSA | 57.61 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 266 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.14 | |
WO2009152082 | 266 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 5.77 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6602 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4914 | Saccharin | DB12418 | |
0.4828 | Sulfabenzamide | DB09355 | |
0.4821 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.4661 | 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide | DB04180 | |
0.4661 | 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide | DB02221 | |
0.4610 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4569 | N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02069 | |
0.4538 | 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide | DB02861 | |
0.4533 | Evatanepag | DB12022 | |
0.4516 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4492 | N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide | DB03844 | |
0.4472 | 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide | DB04549 | |
0.4436 | N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide | DB02610 | |
0.4429 | AL5927 | DB03526 |